Pearls & Oy-sters: Isolated cerebral zygomycosis in an intravenous drug user

Neurology

Volumn 76, Issue 1, 2011, Pages

  Clark, David ^a   Al Mohajer, Mayar ^a   Broderick, Joseph ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B LIPID COMPLEX; ANTICONVULSIVE AGENT; BERLOCOMBIN; CEFTRIAXONE; COTRIMOXAZOLE; METRONIDAZOLE; VANCOMYCIN;

ADULT; ARTICLE; ASPERGILLOSIS; BRAIN DAMAGE; BRAIN DISEASE; BRAIN INFECTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRANIECTOMY; DECEREBRATION; HEADACHE; HEMIPLEGIA; HUMAN; INTRAVENOUS DRUG ABUSE; MALE; MUCORMYCOSIS; PRIORITY JOURNAL; SEIZURE; WALKING DIFFICULTY; ZYGOMYCOSIS;

EID: 78751633756     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318203e92b     Document Type: Article

References (7)

1. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005;41:634-653.
2. Verma A, Brozman B, Petito CK. Isolated cerebral mucormycosis: report of a case and review of the literature. J Neurol Sci 2006;240:65-69.
3. Sundaram C, Mahadevan A, Laxmi V, et al. Cerebral zygomycosis. Mycoses 2005;48:396-407.
4. Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 2006;25:215-229.
5. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000;13:236-301.
6. Hopkins RJ, Rothman M, Fiore A, Goldblum SE. Cerebral mucormycosis associated with intravenous drug use: three case reports and review. Clin Infect Dis 1994;19:1133-1137.
7. Greenberg RN, Mullane K, van Burik JA, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006;50:126-133.